▲ Peaking
Business
Foghorn lays off 40% of employees as Lilly cancer collab collapses over poor data
Foghorn Therapeutics slashes 40% of its workforce after Lilly pulls a cancer partnership, sending its stock tumbling.
Biotech Layoffs
2 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Biotech Layoffs
This hub groups 2 separate news trends connected to Biotech Layoffs, spanning August 26, 2026 through October 2, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 13 article observations and 13 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg
Bristol Myers Squibb ends blood‑cancer deal, prompting Cellares to cut 100 jobs and reorganize.